Drug Shortage Report for MYLAN-GLICLAZIDE MR
| Report ID | 251242 |
| Drug Identification Number | 02438658 |
| Brand name | MYLAN-GLICLAZIDE MR |
| Common or Proper name | GLICLAZIDE MR |
| Company Name | MYLAN PHARMACEUTICALS ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | GLICLAZIDE |
| Strength(s) | 30MG |
| Dosage form(s) | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 100BT |
| ATC code | A10BB |
| ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2025-07-31 |
| Actual start date | |
| Estimated end date | 2025-08-26 |
| Actual end date | 2025-08-05 |
| Shortage status | Resolved |
| Updated date | 2025-08-06 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v31 | 2025-08-06 | English | Compare |
| v30 | 2025-08-05 | French | Compare |
| v29 | 2025-08-05 | English | Compare |
| v28 | 2025-08-01 | English | Compare |
| v27 | 2025-07-07 | French | Compare |
| v26 | 2025-07-07 | English | Compare |
| v25 | 2025-07-02 | French | Compare |
| v24 | 2025-07-02 | English | Compare |
| v23 | 2025-06-24 | French | Compare |
| v22 | 2025-06-24 | English | Compare |
| v21 | 2025-06-17 | French | Compare |
| v20 | 2025-06-17 | English | Compare |
| v19 | 2025-05-21 | French | Compare |
| v18 | 2025-05-21 | English | Compare |
| v17 | 2025-05-05 | French | Compare |
| v16 | 2025-05-05 | English | Compare |
| v15 | 2025-04-14 | French | Compare |
| v14 | 2025-04-14 | English | Compare |
| v13 | 2025-04-09 | French | Compare |
| v12 | 2025-04-09 | English | Compare |